CIK cells engineered with a CAR that was directly targeted against carcino-embryonic antigen (CEA) showed improved activation toward CEA+ colon carcinoma cells, compared to that of CEA− cells (15). The gene discussed is CEACAM5; the disease is colon carcinoma.